Herpes simplex
Herpes simplexHerpes simplex virusNeonatal herpes simplexHerpesviral encephalitisHerpes simplex researchHerpes labialisEpidemiology of herpes simplexHerpes simplex virus protein vmw65Herpetic keratoconjunctivitisGingivostomatitisHerpes zosterErythema multiformeErythema multiforme minorHerpesviridaeVirusHIVEncephalitisAciclovirAlphaherpesvirinaeCondom
Eczema herpeticumHerpesviral meningitisHerpetic sycosisHerpes esophagitisVidarabineHerpes gladiatorumHerpes genitalisHSVTromantadineHSV-2Cowdry bodiesCapsidVp16Alzheimer's diseaseHerpes support groupsHHV Infected Cell Polypeptide 0Neurotropic virusSatellite glial cellList of MeSH codes (C02)Bell's palsy
Vical Announces Publication of Herpes Simplex Vaccine Mouse Study Data - MarketWatch (press release)
Posted by admin / Under Herpes Simplex
Vical Announces Publication of Herpes Simplex Vaccine Mouse Study Data MarketWatch (press release) HSV-2 is a sexually transmitted virus which is the leading cause of genital herpes. Approximately one out of every six individuals in the United States and an estimated one out of every four worldwide is infected by HSV-2 before age 50. |
Published on Tuesday 22nd of May 2012 07:02:01 PM
Vical Reveals Publication Of Herpes Simplex Vaccine Mouse Study Data - NASDAQ
Posted by admin / Under Herpes Simplex
Vical Reveals Publication Of Herpes Simplex Vaccine Mouse Study Data NASDAQ ... the online publication of a new article in The Journal of General Virology detailing results from the company's completed mouse studies with the company's Vaxfectin-formulated plasmid DNA vaccines against herpes simplex virus type 2, or HSV-2. |
Published on Tuesday 22nd of May 2012 07:02:01 PM
Vical Updates Herpes Simplex Vaccine Development at ASGCT Conference - MarketWatch (press release)
Posted by admin / Under Herpes Simplex
Vical Updates Herpes Simplex Vaccine Development at ASGCT Conference MarketWatch (press release) PHILADELPHIA, May 16, 2012 (GlobeNewswire via COMTEX) -- Vical Incorporated (NASDAQ:VICL) today announced that results from multiple animal studies with the company's Vaxfectin(R)-formulated plasmid DNA (pDNA) vaccines against herpes simplex virus type ... |
Published on Tuesday 22nd of May 2012 07:02:01 PM
Vical Updates Herpes Simplex Vaccine Development at ASGCT Conference - NASDAQ
Posted by admin / Under Herpes Simplex
Vical Updates Herpes Simplex Vaccine Development at ASGCT Conference NASDAQ PHILADELPHIA, May 16, 2012 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that results from multiple animal studies with the company's Vaxfectin®-formulated plasmid DNA (pDNA) vaccines against herpes simplex virus type 2 (HSV-2) ... |
Published on Tuesday 22nd of May 2012 07:02:01 PM
Genocea Highlights Key Progress in the Development of its First Vaccine ... - MarketWatch (press release)
Posted by admin / Under Herpes Simplex
Genocea Highlights Key Progress in the Development of its First Vaccine ... MarketWatch (press release) CAMBRIDGE, Mass., May 04, 2012 (BUSINESS WIRE) -- Genocea Biosciences announced today the results of two studies that showcase the company's efforts to develop the first-ever therapeutic vaccine for HSV-2 (herpes simplex virus type 2). |
Published on Tuesday 22nd of May 2012 07:02:01 PM
Managing Sexually Transmitted Infections in Pregnant Women - Medscape
Posted by admin / Under Herpes Simplex
Managing Sexually Transmitted Infections in Pregnant Women Medscape The common STIs that are known to have significant implications in pregnancy are Chlamydia trachomatis, Neisseria gonorrhoeae, human papilloma virus (HPV), herpes simplex virus (HSV), Trichomonas vaginalis and syphilis. This review outlines the ... |
Published on Tuesday 22nd of May 2012 07:02:01 PM
GenVec Appoints Cynthia Collins as President and CEO - MarketWatch (press release)
Posted by admin / Under Herpes Simplex
GenVec Appoints Cynthia Collins as President and CEO MarketWatch (press release) GenVec's development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), herpes simplex virus (HSV), dengue fever, malaria, ... |
Published on Tuesday 22nd of May 2012 07:02:01 PM
FDA Approves Foscarnet for HIV-Related CMV Retinitis, Herpes - Medscape
Posted by admin / Under Herpes Simplex
FDA Approves Foscarnet for HIV-Related CMV Retinitis, Herpes Medscape Foscarnet sodium is now indicated for the treatment of CMV retinitis in patients with HIV and acyclovir-resistant mucocutaneous herpes simplex virus infections in immune-compromised patients in the United States, in addition to its availability in ... |
Published on Tuesday 22nd of May 2012 07:02:01 PM
HEALTH CARE AND HERPES - The Cypress Times
Posted by admin / Under Herpes Simplex
 The Cypress Times | HEALTH CARE AND HERPES The Cypress Times According to WebMD, herpes simplex viruses -- more commonly known as herpes -- are categorized into two types: herpes type 1 (HSV-1, or oral herpes) and herpes type 2 (HSV-2, or genital herpes). Most commonly, herpes type 1 causes sores around the ... |
Published on Tuesday 22nd of May 2012 07:02:01 PM
GenVec Appoints Cynthia Collins as President and CEO - PR Newswire (press release)
Posted by admin / Under Herpes Simplex
GenVec Appoints Cynthia Collins as President and CEO PR Newswire (press release) GenVec's development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), herpes simplex virus (HSV), dengue fever, malaria, ... |
Published on Tuesday 22nd of May 2012 07:02:01 PM
Find news
Share this!